Avecho Biotechnology LimitedASX: AVE

AVE receives final ethics approval for Phase III CBD trial

Mar 7, 2024 at 3:52 AM UTC · Issued by Avecho Biotechnology Limited

Avecho Biotechnology Ltd has released a press release.

View Attachment